Clinical Trial Update: Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 dose-escalation trial evaluated the pharmacokinetics of atazanavir when co-administered with rifampicin in HIV-positive adults on second-l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Rifampicin

Snippet

Sponsor: University of Liverpool | Conditions: HIV/AIDS, Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED